Plus: carcinogen in some generic versions of metformin; ADA COVID-19 resources; insulin Medicare cap; more
Can't see the images? View as webpage.
Facebook
Twitter
LinkedIn
To ensure that you never miss an issue, please whitelist us.

May 30, 2020: Issue #1044

TOP STORIES - Diabetes News & Research

Could Skipping Breakfast Cost Your Patient with Type 2 Diabetes Their Cardiovascular Health?

How A Healthy Lifestyle Affects Life Expectancy Free of Comorbidities

Male and Female Influence of Metabolic Syndrome in People with Type 2 Diabetes
Letter from the Editor

The news about the corona virus can be overwhelming for the healthiest person, but if you have a disease like diabetes all you hear is how much more risk you have of serious complications. Typically the news feeds don’t fully explain the whole story and often only the worst is presented. This week our publisher Steve Freed worked with the American Diabetes Association to ferret out the whole story on what your patients see and hear. He has put together a group of links that deliver what we feel are the most valuable insights.

Take a look at his list and short description and click the link to download what you want to review.

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief


Doctor's Option lab test products include rapid tests and CLIA certified fingerstick lab tests.

Rapid tests offer immediate test results to provide doctors with point of care test results in as little as 90 seconds.

Fingerstick lab tests provide CLIA certified lab accurate results. Each fingerstick lab test collection kit comes with a prepaid postage return envelope and everything you need to obtain and collect your fingerstick blood sample in a 510K FDA approved device.

Fingerstick lab tests are great for people who want to monitor their blood sugar, cholesterol, lipids and other important bio-markers at home or on the go.

Visit Doctor's Option

Newsflash: Safety Recall for Some Generic Metformins; Medicare Insulin Price Cap; ADA COVID-19 Resources

 
  • FDA Finds Carcinogen in Some Generic Versions of Metformin:  U.S. regulators are contacting pharmaceutical companies that make long-acting metformin medications.  The FDA discovered N-Nitrosodimethylamine, or NDMA, beyond acceptable amounts in some extended-release versions of metformin. About 21 million prescriptions for the extended-release version were written in the U.S. last year. This recall has been announced:

    • Metformin Hydrochloride Extended-Release Tablets 500 mg by Apotex: Recall Due to Detection of N-Nitrosodimethylamine (NDMA)

    FDA Alert

  • American Diabetes Association® Secures Insulin Price Reductions for Seniors Through New CMS Senior Savings Model - New Program Will Cap Medicare Monthly Co-Pays at $35. More info.

  • ADA resources for Diabetes and COVID-19: Hear from over 40 Diabetes Professionals. See this week’s Did You Know? for more. 

TOP STORIES - Diabetes News and Research

Could Skipping Breakfast Cost Your Patient with Type 2 Diabetes Their Cardiovascular Health?
Arterial stiffness is a complication of cardiovascular disease; does skipping meals contribute to this condition in patients with type 2 diabetes mellitus?
READ MORE
How A Healthy Lifestyle Affects Life Expectancy Free of Comorbidities
As we continue to age, lifestyle choices play a big part in how chronic diseases develop and impact daily life.
READ MORE
Male and Female Influence of Metabolic Syndrome in People with Type 2 Diabetes
Of the many ways diabetes can complicate a person's life, metabolic syndrome is one more thing to add to the list, especially in women.
READ MORE

Did You Know? Where you can find resources for medical professionals for information on Diabetes and COVID-19:


The American Diabetes Association has pulled together resources relevant to diabetes and COVID-19 for professionals treating patients with diabetes.  Topics include inpatient care, practice safety, caring for patients experiencing unemployment, the impact of diabetes and quarantine on youth, and many more. Download the resources in PDF format: Diabetes and COVID-19

Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters:

Deonna Andrews, PharmD Candidate 2020 of Florida Agricultural & Mechanical University College of Pharmacy and Pharmaceutical Sciences  

Adam Chalela B.S., PharmD Candidate, USF College of Pharmacy Class of 2020

Mia Flowers, PharmD. Candidate of Florida Agricultural & Mechanical University  School of Pharmacy 

Karlena Pope, PharmD Candidate, South College School of Pharmacy  

Chardae Whitner PharmD Candidate L|E|C|O|M Bradenton School of Pharmacy
 About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.
Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com
Facebook
Twitter
LinkedIn
©2020 HIPER, LLC. All rights reserved.

This email was sent by eHealthcare Solutions on behalf of:
Diabetes In Control
810 Bear Tavern Rd, Suite 102
Ewing, NJ, 08628, United States

DiabetesInControl.com | Contact Us
Subscription Center | Update Profile
Unsubscribe